US 10231932
Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
granted A61KA61K31/443A61K31/47
Quick answer
US patent 10231932 (Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/443, A61K31/47, A61K45/06, A61K9/146